Science Explorer Interactive view Map
Company · Hørsholm · Denmark

MC2 Therapeutics (Denmark)

mc2therapeutics.comROR OpenAlex
Research works
28
▲ 453% vs 2013–17
Citations
131
4.6 per fractional work
Top-10% rate
1.1%
record average 16.5%
Open access
67%
world 28%

Not ranked overall: MC2 Therapeutics (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.10× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 17.44× its world share, 3 worksImmunology and Micro…Neuroscience: 2.00× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 21.90× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.15× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.21× its world share, 1 worksEngineeringMaterials Science: 0.18× its world share, 0 worksMaterials ScienceDentistry: 2.48× its world share, 0 worksDentistryHealth Professions: 0.47× its world share, 0 worksHealth ProfessionsMedicine: 2.32× its world share, 8 worksMedicineNursing: 0.54× its world share, 0 worksNursingPsychology: 0.12× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 21.9×. Every wedge is a field page.

Which keywords describe research at MC2 Therapeutics (Denmark)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Inflammatory Cytokines, Inflammation, Staging System, Regulatory T Cells, Targeted Therapy, Immune System and IL-17.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Immunotherapy3▲ 18×12 topics
  2. Inflammation3▲ 4.8×16 topics
  3. Inflammatory Cytokines3▲ 134×2 topics
  4. Epidemiology3▲ 2.3×12 topics
  5. Staging System2▲ 114×2 topics
  6. Regulatory T Cells2▲ 57×2 topics
  7. Targeted Therapy2▲ 29×5 topics
  8. Immune System2▲ 18×2 topics
  9. IL-172▲ 228×1 topic
  10. TH17 Cells2▲ 228×1 topic
  11. Genetic Mutations2▲ 10×5 topics
  12. Thrombosis2▲ 24×4 topics
  13. Prognosis1▲ 15×3 topics
  14. Therapy1▲ 23×2 topics
  15. Neurodegeneration1▲ 15×4 topics
  16. ALK1▲ 130×1 topic
  17. Chemotherapy1▲ 6.0×6 topics
  18. Neuroblastoma1▲ 130×1 topic
  19. PET Imaging1▲ 20×4 topics
  20. Clinical Trials1▲ 6.5×4 topics
  21. Dry Eye Disease1▲ 108×1 topic
  22. Immune Response1▲ 6.3×5 topics
  23. Microneedles1▲ 167×1 topic
  24. Nanoparticles1▲ 2.9×2 topics
  25. Ocular Surface1▲ 108×1 topic
  26. Solid Lipid Nanoparticles1▲ 167×1 topic
  27. Treatment1▲ 2.9×6 topics
  28. Filaggrin1▲ 87×1 topic
  29. Immune Dysregulation1▲ 45×2 topics
  30. Skin Microbiome1▲ 87×1 topic

Which research topics does MC2 Therapeutics (Denmark) publish most on?

By volume in 2022–2025: Psoriasis: Treatment and Pathogenesis, Advancements in Transdermal Drug Delivery, Platelet Disorders and Treatments and Dermatology and Skin Diseases.

Psoriasis: Treatment and…2Psoriasis: Treatment and Pathogenesis: 2 fractional worksAdvancements in Transdermal Drug Delivery: 1 fractional worksPlatelet Disorders and T…1Platelet Disorders and Treatments: 1 fractional worksDermatology and Skin Dis…1Dermatology and Skin Diseases: 1 fractional worksNeuroblastoma Research and Treatments: 1 fractional worksCoagulation, Bradykinin, Polyphosphates, and Angioedema: 0 fractional worksMultiple Myeloma Researc…0Multiple Myeloma Research and Treatments: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksPharmaceutical studies and practices: 0 fractional worksRadiopharmaceutical Chemistry and Applications: 0 fractional works
ImmunologyPharmaceutical ScienceHematologyDermatology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  2. 2 Advancements in Transdermal Drug Delivery Pharmaceutical Science 1 works
  3. 3 Platelet Disorders and Treatments Hematology 1 works
  4. 4 Dermatology and Skin Diseases Dermatology 1 works
  5. 5 Neuroblastoma Research and Treatments Neurology 1 works
  6. 6 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 0 works
  8. 8 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  10. 10 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.8%not open33.2%

World: 28% of research is openly available.

with international co-authors63.6%domestic only36.4%

World: 19% is written across borders.

How has MC2 Therapeutics (Denmark)'s research output changed?

Output in 2018–2022 was 453% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hørsholm

All research institutions in Hørsholm

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.